Most of the patients mixed up in trials – which were released before November 2009 – acquired received an ARB called telmisartan. Researchers discovered that patients who took ARBs had been more likely to end up being newly identified as having cancer than those who didn’t . Among solid cancers, the only one to be associated with an increased risk among ARB users was lung cancers. The researchers also observed no significant upsurge in cancers deaths among ARB users, although they remarked that the trials they looked at only had short follow-up intervals. Related StoriesMD Anderson study reveals why chemotherapy medicines not effective for most pancreatic cancer patientsMeat-rich diet plan may increase kidney cancers riskViralytics enters into clinical trial collaboration contract with MSDThey also observed that the research had only viewed three ARBs , meaning that their conclusions can’t be used to ARBs generally... Abnormalities in certain genes may cause autism: Research With colleagues from an international research group Together, autism researcher Christopher Gillberg of the University of Gothenburg, Sweden, has within a new study that autism could be explained by abnormalities in certain genes partially. The group’s results could, over time, pave just how for more appropriate remedies for autism. Prestigious journal Nature is publishing articles co-authored by Christopher Gillberg of the machine for Kid and Adolescent Psychiatry at the Institute of Neuroscience and Physiology, and person in the Autism Genome Task research group. In this article the group reveals that a survey of 1 1,000 people with autism and 1,300 without showed that Copy Amount Variants – sub-microscopic abnormalities in the chromosomes – are heavily over-represented in autistic people.